CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know

CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
This story originally appeared on Zacks

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $82.15, marking a +0.72% move from the previous day. The stock outpaced the S&P 500’s daily gain of 0.62%. Meanwhile, the Dow gained 0.55%, and the Nasdaq, a tech-heavy index, lost 0.03%.

CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know – Zacks

Heading into today, shares of the company had gained 1.52% over the past month, lagging the Medical sector’s gain of 2.92% and outpacing the S&P 500’s gain of 0.87% in that time.

Investors will be hoping for strength from CRISPR Therapeutics AG as it approaches its next earnings release. The company is expected to report EPS of -$1.74, down 16% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $5.39 million, up 1356.22% from the year-ago period.

For the full year, our Zacks Consensus Estimates…

Continue reading

Leave a Reply

Your email address will not be published. Required fields are marked *